CIRM Stingy with Info on Matters Before Directors This Week
With less than three business days left before Thursday's meeting of the directors of the $3 billion stem cell agency, CIRM has not yet produced details for the public on three significant matters that are to be considered.
The agency's failure to provide the information for the biotech industry, researchers, patient advocates, policy makers and the publ…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.